In this regard, amongst the TCRs recognising these dominant peptides, we observed high usage of V gene TRBV20‐1 [56] and J gene TRBJ2‐1 [57] (Figure S4d), which have been previously reported to have implications in COVID‐19 patients. This evidence concerns the gene TRBV20-1 and COVID-19.